By radioreceptor binding studies with iodinated TGF-β1, it has been shown that an undifferentiated ES-5 cell expresses approximately 3270 receptors with a dissociation constant Kd=130pM, but after the induction of differentiation by retinoic acid and dBcAMP, the receptor number of a differentiated RA-ES-5 cell was increased about 80% and the Kd was also increased to 370 pM. Furthermore, more direct evidence supporting the expression of TGF-β type I and type II receptors in both ES-5 and RA-ES-5 cells has come from dot blot hybridization of cellular mRNA with cDNA probes for type I and type II receptors. Meanwhile, mRNA expression level of types I and II receptors in RA-ES-5 cells were higher than that in ES-5 cells. Down-regulation of TGF-β receptors with a significant decrease in the rate of cell proliferation in both cells, was found by employing a pretreatment with neutralizing antibody to TGF-β1. The possible role of receptors for TGF-β in cell differentiation is discussed here.
INTRODUCTION
Transforming growth factor-βs (T G F -βs ) are known to be a multifunctional growth regulators. TGF-βs have been proved to play an important role in cell growth and differentiation during embryogenesis [1] . By immunohistochemical procedure, we have also found that abundant TGF-β1 is present in preimplantation mouse embryos including cleavage, morula and blastocyst stages. In postimplantation embryos, the distribution of TGF-β1 appears to be related to the differentiation of endoderm and mesoderm, particularly in the histogenetic events in conjunction mainly with mesoderm or mesenchyme cells [2] . It has been reported that the biological effects of TGF-βs are controlled by specific binding of cell surface receptors to TGF-βs. Three types of receptor for TGF-β, named type I, II and III have been identified. From studies on mutated cells and certain tumor cell lines lacking TGF-β responsiveness, types I and II receptors were shown to be essential for TGF-β signalling, while type III (or betaglycan) might play a role in the retention or delivery of TGF-β [3] . TGF-β isoforms bind with different affinities to receptors but each isoform is able to associate with all three receptors [4] . In general, the affinity of the types I and II receptors is higher for TGF-β1 and TGF-β3 than TGF-β2; however, the relative affinities vary with cell types [5] . Only recently, types I, II and III receptors for TGF-βs have been cloned and characterized [6] [7] [8] . This provides an immediate strategy for the study of receptor expression during early mouse development as well as in an in vitro system of embryonic stem cells (ES cells), as a model for studying growth and differentiation of mammalian embryonic cells [9] . So far, little is known about the characteristics of TGF-β receptors in ES cells and their corresponding differentiated cells. In our earlier experiments, ES-5 cells had been induced to differentiate into more than 90% glial-like cells by retinoic acid (RA) and dBcAMP and these ES-5 cells, and their differentiated glial-like cells, both expressed TGF-β1, in varying degrees [10] . In this study we further investigated the affinity, number and types of TGF-β receptors in ES-5 ceils and their differentiated derivatives by radioreceptor binding assay of 125 I-labeled TGF-β1 purified from human platelets and dot blot hybridization with cDNA probes for types I and II TGF-β receptors. We also demonstrated the increasing expression of types I and II receptors for TGF-β in differentiated cells treated with RA and dBcAMP. Down-regulation of TGF-β1-binding sites in the surface of both these ceils was found by the pretreatment with neutralizing antibody to TGF-β1. The possible role of receptors for TGF-β in cell differentiation is discussed.
MATERIALS AND METHODS

Culture and induced differentiation of ES-5 Cells
ES-5 cell line was isolated from the inner cell mass of delayed blastocyst of a 129/SV strain mouse [11] , and cultured in 80% BRL-CM containing 20% fetal calf serum (FCS) and 10 -4 M β-mercaptoethanol. Differentiation was induced as described previously [10] . In short, 4 hrs after the plating of ES-5 ceils, RA and dBcAMP were added to the BRL-CM at a final concentration of 10 -6 M and 1 mM respectively. On day 3 the medium was refreshed. ES-5 cells and their differentiated cells (RA-ES-5 cells) induced by RA and dBcAMP were cultured for 6 days in 10 cm dishes. Before ra-dioreceptor binding assay, both cells were dissociated with 0.25% trypsin and 0.2 mM EDTA in PBS at 37℃ for 5 min and the final cell number in each well of 24 well plates was controlled at 4×10 5 /ml.
Radioiodation of TGF-β1
Iodation of TCF-β1 was performed with Indo-bead shaking procedure established in our institute. Briefly, 2 μg TGF-β1 purified from human platelets according to Assoian et al [12] was dissolved in 10 μl 0.175 M acetic acid, then 1 mci Na 125 I (Amersham) and 0.05 M, pH7.6 phosphatebuffered solution were added to a final volume of 500 μl in a plastic tube. Two Indo-beads(Nchlorobenzesulfonmide) were added and mixed on a shaker at room temperature for 15 min. Free 125 I was removed from reaction mixture by chromatography on Sephadex G-25. Fraction of 125 I-TGF-β with highest radioactivity were collected and stored at -30℃.
3. TGF-β receptor binding assay TGF-β receptor binding assay was carried out according to Enna [13] . Trypsinized ES-5 and RA-ES-5 cells attached separately to 24 well plates f or 2-3 hrs were washed once with DMEM without calf serum and then once with binding assay buffer (BAB: MEM containing 0.1% BSA, 25 mM Hepes, freshly prepared before use). A fixed amount of 125 I-TGF-β1 (5 x 10 4 cpm/well) was added to each well and an increasing concentration of unlabeled TGF-β1 (0-40 ng/ml) to different wells were added and all supplemented with BAB to a final volume of 300 μl/well. Non-specific binding assay was carried out by using a large quantity of unlabeled TGF-β1 (20-100 ng/well more than 100 times of the amount of 125 I-TGF-β1 used ). The reaction was allowed to proceed to equilibrium for 60 min in 5% CO 2 incubator at 37℃. The cells were washed 3 times with precooled Hank' s solution containing 0.1 % BSA and the cell membranes were solubilized in 0. 
Scatchard analysis of receptor binding experiments
The most commonly used approach for data processing of ligand-receptor binding experiments is the preparation of a Scatchard plot of the B/ F (amount of bound 125 I-TGF-β1 /amount of flee 125 I-TGF-β1) ratio (Y axis) Vs bound ligand concentration (X axis) [14] . The Scatchard equation is B /F=1 /Kd ( R 0 -B). The values of B and B /F can be obtained from the transformation of data measured in the receptor binding experiments. The maximum amount of ligand bound to cell surface (Bmax) is X axis intercept from which the receptor number on each cell surface can be obtained. Kd is equilibrium dissociation constant.
Treatment of ES-5 and RA-ES-5 cells with antibody to TGF-β1
When the number of ES-5 and RA-ES-5 ceils was set at 4×10 5 /well in 24 well plates respectively, the cells were washed once with BRL-CM/FCS medium without an inducing agent. T hen sufficient amount of neutralizing antibodies for TGF-β 1 [15] were added to each well and incubated for 18 hrs at 37℃ the before radioreceptor binding assay. The final concentrations of affinity-purified anti-TGF-β1 IgG used in the well were varied at range of 1-50 μg/ ml. Control IgG was purified from a mouse normal serum. The cell numbers in each well treated by the antibody to TGF-β l was estimated by the MTT method [16] . For TGF-β receptor binding assay, both ES-5 and RA-ES-5 ceils pretreated with TGF-β antibody were trypsinized and the cell number was adjusted at 4×10 5 /well. 6 . Probes for TGF-β type I and type H receptors and dot blot analysis.
The individual plasmids containing TGF-β RI and TGF-β RII cDNA were generously provided by Dr. Xiao-Fan Wang (Department of Pharmacology, Duke University Medical Center. Durham, North Carolina). 1.7 Kb EcoRI-HindIII fragment of TGF-β RI and 1.2 Kb EcoRI-SacI fragment of TGF-βRII were used as hybridization probes and labeled respectively with [ 32 P]dATP (3000ci /mmol, Amersham) by random priming (GIBCO /BRL). The probes were labeled to a specific activity of 1×10 8 cpm/μg for TGF-βRI and 9.3×10 7 cpm/μg for TGF-βRII using 32 PdATP, reepectively.
According to the methods described in"Molecular Cloning-A Laboratory Manual" edited by J. Sambrook et al [17] , extraction of total RNA from ES-5 and RA-ES-5 cells grown in culture was carried out with guanidine isothiocyanate and organic solvent, and poly(A) + RNA was purified from the individual preparation of total cellular RNA by chromatography on Oligo(dT)-cellulose. Poly(A) + RNA samples were applied onto the nylon membrane (Qiabrane) with the Manifold II (Schleicher and Schuell). After all of the samples were passed through the membrane, was each spot rinsed twice with 10 x SSC. The membranes were then removed from the manifold and allowed to dry completely at room temperature, they were then baked for 2 h at 80℃ in a vacuum oven and stored in a plastic bag. Dot hybridization were performed respectively with the 32 P-labeled DNA probes for TGF-βRI and TGF-βRII at 42℃ in hybridization buffer containing 50 % formamide overnight and blots were washed in 0.2 x SSC, 0.1 % SDS. The membranes were exposed to X-ray film at -70℃ for 4-7 days with an intensifying screen. Later quantification of dot blot was carried out by UltroScan XL laser densitometer (Pharmacia LKB).
RESULTS
Demonstration of TGF-β1 binding to receptors in ES-5 and RA-ES-5 cells Incubation of ES-5 and RA-ES-5 cells at 4 x 10
5 /well respectively with increasing concentration of unlabeled TGF-β1 (0-40 ng/ ml) and a fixed amount of 125 I-TGF-β1 (5x 10 4 cpm /well) showed a competitive binding curve (Fig 1) . Taking the binding rate of 125 I-TGF-β1 when concentration of unlabeled TGF-β1 was at 0 ng/ml as 100%, and the binding of 125 I-TGF-β1 was decreased in wells with increasing amounts of unlabeled TGF-β1. Nonspecific binding was determined using an excess of unlabeled TGF-β1 in one well for each incubation. More than 90% of the bound 125 I-TGF-β1 was displaced by the highest dose of unlabeied TGF-β1 tested (100ng/ml). The specific binding was calculated by substracting nonspecific binding from total binding. The results demonstrated the presence of specific receptors for TGF-β1 in both ES-5 and RA-ES-5 cells. 
Expression of TGF-β type I and II receptor RNA in ES-5 and RA-ES-5 cells
Dot blot hybridization of total RNA isolated from ES-5 and RA-ES-5 cells with the probes for TGF-βRI and TGF-βRII showed that both ES-5 cells and RA-ES-5 cells expressed the two receptor mRNAs, but mRNA level of TGF-βRI was higher than that of TGF-βRII in both cells (Fig 3) . However, the differentiated cells, and this expressed more TGF-βRI and TGF-βRII mRNA than undifferentiated parent cells which was particularly evident from the scanning data of low-loaded samples, as shown in Tab 2. The results thus suggested that the expression level of mRNAs for TGF-βRI and TGF-βRII was somewhat increased after induced differentiation and this increase was conformable to the data of TGF-β receptor binding assay mentioned above. Note that when the amount of total RNA loaded was 10 μ g for each dot, the expression level of mRNA for TGF-βRI and TGF-βRII was increased by about 87% for RI ( compare B-2 to B-1) and 56% for RII (compare D-2 to D-l) after ES-5 cells were differentiation into RA-ES cells, although no significant change was found in case 20 μ g of total RNA was loaded (compare A-1 and A-2, C-1 and C-2), possibly due to the high background.
Effect of TGF-β1 antibody on ES-5 and RA-ES-5 cells a. Growth inhibition of ES-5 and RA-ES-5 cells
The growth inhibition of ES-5 and RA-ES-5 cells followed the treatment of them with a monoclonal antibody against human TGF-βl. The percentage of inhibition in both types of cells increased with increasing concentration of the antibody IgG tested. In the same concentration of TGF-β1 IgG, inhibitory effect on RA-ES-5 cells appeared to be higher than that of ES-5 cells. When the dose of TGF-βI antibody IgG was increased up to 50 μ g /ml, the growth inhibition of RA-ES-5 cells reached 61%, but it only reached 46% in the ES-5 cells. In a controlled experiment with mouse IgG, no effect on growth of both cells was found in corresponding concentration (Fig 4) . 
DISCUSSION
The interaction of TGF-β with target cells involves a set of membrane proteins with both a distinct structure and function. It has been shown that there exist membrane proteins binding to TGF-β in many cell types a using receptor affinity labeling procedure [4] [5] . Binding studies with iodinated TGF-β 1 have shown that undifferentiated EC and ES cells have low levels of cell surface receptors for TGF-β. After the induction of differentiation by RA, however, high affinity binding sites for TGF-β 1 become detectable [18] [19] . In this study we have carried out TGF-β 1 binding experiments and dot blot hybridizations for TGF-β type I and type II receptors on undifferentiated ES-5 cells and their differentiated derivatives. Preliminary resuits have shown that an undifferentiated ES-5 cell expressed approximately 3270 receptors with a dissociation constant Kd=130pM. This number was increased by about 80% when ES-5 cells were differentiated into a population of glial-like ceils by RA and dBcAMP. Concomitantly, the Kd was increased to 370 pM. Our results which are slightly different from that from other reports [19] , may be due to the fact that we have used trypsinized ES-5 ceils which are easy to grow in vitro in form of aggregates in the presence of LIF/ DIA. We have made some trial experiments to test the effect of trypsinization before receptor binding assay, and found that the number of binding sites was variable in non-trypsinized ES-5 cells, often being less than that of trypsinized ES-5 cells. On the other hand, RA-ES-5 cells grown in single cells did not display any significant change in the number of binding sites regardless of whether cells were treated with trypsin or not. Since most of ES-5 cells sampled without trypsinization contained a number of small aggregates, it appears that cell aggregation might cause an apparent decrease in the number of TGF-β binding sites in radioreceptor binding assay.
Recently, it was reported that undifferentiated ES cells and differentiated ES cells all produced a significant amount of biologically active TGF-β [20] and the TGF-β1 has been detected in the ES-5 cell line [21] . Meanwhile, ES cells and their differentiated cells have been shown to be responsive to TGF-β [22] . It is therefore not surprising to find specific, high affinity receptors for TGF-β in these cells. In general the number and affinity of TGF-β receptors on the cell surface might reflect the difference in cellular function and capacity to grow or differentiate. However, no definite relationship between the number of TGF-β receptor and sensitivity to growth inhibition by TGF-β has been found in several cancer lines [23] [24] . Moreover, some results indicated that the difference between TGF-β responsive and nonresponsive cells with regard to their total number of high affinity receptors was small [25] .
Further studies, constequently, will be required to define the relationship between the number/affinity of TGF-β receptors and their ability to regulate growth and differentiation in ES cells.
In the present studies, more direct and consistent evidence supporting the expression of TGF-β type I and type II receptors in both undifferentiated ES-5 cells and their differentiated derivatives has come from dot blot hybridization of individual cellular mRNA with cDNA probes for TGF-β RI and TGF-β RII. With respect to general properties of three types of TGF-β receptors, only types I and II receptors are directly involved in TGF-β signaling. In fact, the intracellular signaling events initiated by TGF-β receptor-ligand interaction are not fully understood. It has been shown that the type I and II receptors might interact with each other in TGF-β signaling. The type II receptor could bind TGF-β in the absence of the type I receptor, but type I receptor could not bind TGF-β in the absence of type II receptor [4] . So it appears that TGF-β signals through a heteromeric complex of the type I and II TGF-β receptors. Recently, It has been shown that the type II receptor belongs to a transmembrane receptor of the serine-threonine kinase family, and the type I receptor has an intrinsic serine-threonine kinase activity, which was essential for signal transduction [8] . Such being the case in our experiments that simultaneous expression both of type I and type II TGF-β receptors occurred in ES cells and their differentiated cells, and the molecular events of TGF-β signal transduction by this TGF-β receptor complex must exist in the process of ES cell differentiation.
One of the common properties of growth factor receptors is the ability of the ligand to down-regulate the receptor. Receptor "down-regulation" , or the ligandinduced decrease in the cellular content of receptors, is a mechanism by which the cells regulate their responsiveness to TGF-β . The decrease in the TGF-β receptor number that occurs in cells exposed to TGF-β antibody is a characterized example of down-regulation. In the present studies we have found that the rate of cell proliferation of ES-5 and RA-ES-5 cells was dramatically reduced by the pretreatment with the monoclonal TGF-β antibody IgG and that the number of TGF-β receptors was also decreased simultaneously to two-three-fold in both groups of cells during the period of the treatment with the TGF-β 1 antibody. The indirect evidence obtained from these data supports the possibility that the neutralization of TGF-β 1 present in cellular micro environment by the TGF-β 1 antibody would result in a decrease in the local concentration of TGF-β content which might induce relevantly downregulation of the TGF-β receptors on cell surface. By this reasoning it seems likely that, at least in vitro, TGF-β antibody may be an effective down-regulating agent for TGF-β receptors. Taken together, our data and those from other papers [19] [20] [21] [22] all suggest that TGF-β which exists in cellular microevironment might act by an autocrine/paracrine mechanism in ES cells and their differentiated cells. TGF-β may act as a direct intercellular signal by regulating proliferation of competent target cells or as indirect signals by inducing the expression of a cascade of other genes which, in turn, trigger specific differentiation events.
